Systemic therapy for intermediate and advanced hepatocellular carcinoma: Sorafenib and beyond

Jean‐Luc Raoul; Masatoshi Kudo; Richard S. Finn; Julien Edeline; María Reig; Peter R. Galle

doi:10.1016/j.ctrv.2018.05.006

Related publications

Editorial Material2020

A new era of systemic therapy for intermediate and advanced stage hepatocellular carcinoma

Masatoshi Kudo

Article2017

Resminostat and sorafenib combination therapy for advanced hepatocellular carcinoma in patients previously untreated with systemic chemotherapy.

Masatoshi Kudo, Baek‐Yeol Ryoo, Ho Yeong Lim, Do Young Kim, Takuji Okusaka, Masafumi Ikeda, Hisashi Hidaka, Jong-Eun Yeon, Eishiro Mizukoshi, Manabu Morimoto, Myung Ah Lee, Kohichiroh Yasui, Yasunori Kawaguchi, Jeong Heo, Sojiro Morita, Tae‐You Kim, Junji Furuse, Kazuhiro Katayama, Takeshi Aramaki, Won Young Tak

Article2024

Systemic Therapy Combined with Locoregional Therapy in Intermediate-stage Hepatocellular Carcinoma

Masatoshi Kudo

Article2008

Sorafenib in Advanced Hepatocellular Carcinoma

Josep M. Llovet, Sergio Ricci, Vincenzo Mazzaferro, Philip Hilgard, Edward Gane, Jean Frédéric Blanc, André Cosme de Oliveira, Armando Santoro, Jean‐Luc Raoul, Alejandro Forner, Myron Schwartz, Camillo Porta, Stefan Zeuzem, Luigi Bolondi, Tim F. Greten, Peter R. Galle, Jean François Seitz, Ivan Borbath, Dieter Häussinger, Tom Giannaris, Minghua Shan, M. Moscovici, D. Voliotis, Jordi Bruix

New England Journal of Medicine

Article2022

New treatment paradigm with systemic therapy in intermediate-stage hepatocellular carcinoma

Masatoshi Kudo

Systemic therapy for intermediate and advanced hepatocellular carcinoma: Sorafenib and beyond

Discussion(0)

Related publications

A new era of systemic therapy for intermediate and advanced stage hepatocellular carcinoma

Resminostat and sorafenib combination therapy for advanced hepatocellular carcinoma in patients previously untreated with systemic chemotherapy.

Systemic Therapy Combined with Locoregional Therapy in Intermediate-stage Hepatocellular Carcinoma

Sorafenib in Advanced Hepatocellular Carcinoma

New treatment paradigm with systemic therapy in intermediate-stage hepatocellular carcinoma